Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature

Autor: Buetler, Vanessa Alexandra, Agbariah, Nada, Schild, Deborah Pia, Liechti, Fabian D, Wieland, Anna, Andina, Nicola, Hammann, Felix, Kremer Hovinga, Johanna A

Publikováno v: Buetler, Vanessa Alexandra; Agbariah, Nada; Schild, Deborah Pia; Liechti, Fabian D; Wieland, Anna; Andina, Nicola; Hammann, Felix; Kremer Hovinga, Johanna A (2022). Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature. Frontiers in medicine, 9, p. 890661. Frontiers 10.3389/fmed.2022.890661

Introduction An increasing number of case reports have associated vaccinations against coronavirus disease 2019 (COVID-19) with immune-mediated thrombotic thrombocytopenic purpura (iTTP), a very rare but potentially life-threatening thrombotic microa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4463b00c6e7b3ec2b8be1958d1be393a
https://boris.unibe.ch/170493/1/fmed-09-890661.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.